Barings’s Novo Nordisk NVO Stock Holding History

Barings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,000	Closed	-$215K	–	874
2016 Q2	$215K	Hold	8,000	–	–	0.01%	848
2016 Q1	$217K	Hold	8,000	–	–	0.01%	874
2015 Q4	$232K	Hold	8,000	–	–	0.01%	832
2015 Q3	$217K	Hold	8,000	–	–	0.01%	838
2015 Q2	$219K	Hold	8,000	–	–	0.01%	901
2015 Q1	$214K	Buy	+8,000	New	+$184K	﹤0.01%	903
2013 Q4	–	Sell	-34,000	Closed	-$575K	–	957
2013 Q3	$575K	Sell	34,000 -40,000	-54%	-$673K	0.02%	570
2013 Q2	$1.15M	Buy	+74,000	New	+$1.23M	0.05%	379

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Barings's NVO Position: Q3 2016 in Review

Barings sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 8,000 shares — an estimated $215K sold.

Barings first reported a position in NVO in Q2 2013 and held it in 8 quarters. The position peaked at $1.15M in Q2 2013. 513 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

Barings reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
Barings sold 8,000 Novo Nordisk shares in Q3 2016, an estimated $215K.
Barings first reported a position in Novo Nordisk in Q2 2013 and held it in 8 quarters.
Barings's Novo Nordisk position peaked at $1.15M in Q2 2013.
513 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Barings's 13F filing for Q3 2016, filed 14 Nov 2016.